A significant breakthrough in understanding the neurobiological underpinnings of schizophrenia has emerged, pinpointing a specific genetic alteration that may profoundly affect how individuals perceive and interact with their environment. This discovery, stemming from collaborative research between the Massachusetts Institute of Technology (MIT) and Tufts University, sheds light on a potential mechanism that could explain the characteristic disconnect from reality experienced by some patients, by disrupting the brain’s fundamental ability to integrate new information and update its internal model of the world.
Schizophrenia, a complex mental health condition affecting approximately one percent of the global population, is often characterized by profound cognitive challenges that extend beyond the more widely recognized symptoms like hallucinations and delusions. A core difficulty lies in the effective utilization of novel data to refine existing understandings, a process essential for coherent thought and adaptive behavior. This ongoing struggle to assimilate fresh input can impede decision-making processes and, over time, contribute to a gradual detachment from shared reality, leading to what is often described as a "wrong reality" experience.
The research team focused their investigation on the gene grin2a, a gene that has previously appeared in large-scale genetic studies as being associated with an elevated risk of developing schizophrenia. Through meticulous experimentation involving laboratory mice engineered to carry a specific mutation within this gene, scientists observed a distinct disruption in a critical neural circuit responsible for the dynamic updating of beliefs and predictions in response to incoming sensory information. This circuit, vital for maintaining a flexible and accurate perception of the world, appears to be compromised when the grin2a gene is altered.
Guoping Feng, a distinguished professor at MIT and a key figure in brain and cognitive sciences, explained the significance of this finding, stating that when this particular neural circuit malfunctions, the brain’s capacity to swiftly incorporate new information is severely hampered. Feng, who is also affiliated with the Broad Institute and serves as an associate director at MIT’s McGovern Institute for Brain Research, expressed a high degree of confidence that this circuit represents a crucial mechanism contributing to the cognitive impairments that form a substantial component of schizophrenia’s pathology.
The study, published in the prestigious journal Nature Neuroscience, was spearheaded by Tingting Zhou, a research scientist at the McGovern Institute, and Yi-Yun Ho, a former postdoctoral researcher at MIT. Both Zhou and Ho were identified as lead authors, with Feng and Michael Halassa, an associate professor of psychiatry and neuroscience at Tufts University, serving as senior authors, underscoring the collaborative nature of this groundbreaking work.
The genetic landscape of schizophrenia is notably intricate, with a substantial hereditary component. The likelihood of developing the disorder escalates significantly with familial history; a risk of ten percent is observed if a parent or sibling is affected, and this figure climbs to a striking fifty percent for identical twins, highlighting the potent influence of genetic factors.
Scientists at the Stanley Center for Psychiatric Research, a division of the Broad Institute, have been instrumental in identifying over one hundred distinct gene variants linked to schizophrenia through comprehensive genome-wide association studies. However, a significant challenge has been the interpretation of these variants, many of which reside in non-coding regions of DNA, whose functional roles are not always immediately apparent.
To circumvent this interpretive hurdle, the research team employed whole-exome sequencing, a sophisticated technique that specifically targets the protein-coding segments of the genome. This targeted approach allowed for the direct identification of mutations occurring within genes themselves, offering a more direct line of inquiry into their functional consequences.
By meticulously analyzing approximately 25,000 genetic sequences from individuals diagnosed with schizophrenia and comparing them with a control group of 100,000 individuals, the researchers were able to pinpoint ten specific genes where mutations demonstrably increased the risk of developing the disorder. The grin2a gene emerged as a critical candidate from this extensive analysis.
The gene grin2a encodes a subunit of the N-methyl-D-aspartate (NMDA) receptor, a vital component of neuronal signaling that is activated by the neurotransmitter glutamate. These receptors are ubiquitous on neurons and play a crucial role in synaptic plasticity, learning, and memory. The newly identified mutation within grin2a was found to directly impact the function of these critical receptors.
To investigate the functional consequences of this mutation, researchers generated laboratory mice that carried the specific grin2a mutation. Tingting Zhou, a lead author of the study, then undertook the task of assessing whether these genetically modified mice exhibited behavioral patterns that mirrored aspects of schizophrenia. While the complex subjective experiences of psychosis, such as hallucinations and delusions, cannot be directly replicated in animal models, scientists can effectively study proxy behaviors related to cognitive functions that are known to be impaired in schizophrenia, such as the processing of new sensory information.
For decades, a prevailing hypothesis in schizophrenia research has posited that psychotic experiences might arise from an impaired capacity to revise or update one’s beliefs when confronted with new evidence. Zhou elaborated on this concept, explaining that the healthy human brain constructs an initial belief about reality, and when new sensory input arrives, this information is used to refine and update that prior belief, leading to a more accurate representation of the current state of affairs. In contrast, individuals with schizophrenia, according to this theory, tend to overemphasize their pre-existing beliefs and are less inclined to integrate current information, resulting in beliefs that become detached from objective reality.
To empirically test this hypothesis, Zhou designed an innovative behavioral task for the mice. The experiment involved a choice between two levers, each associated with a different reward structure. One lever offered a low reward, requiring six presses to yield a single drop of milk, while the other provided a higher reward, delivering three drops per press. Initially, all mice, regardless of their genetic makeup, gravitated towards the more lucrative, high-reward lever.
However, the experimental conditions were subtly altered over time. The effort required to obtain the reward from the high-reward lever was gradually increased, while the low-reward lever remained constant. In this dynamic environment, healthy mice, referred to as wild-type animals in scientific literature, demonstrated remarkable adaptability. As the effort for the high-reward option became comparable to the low-reward option, they would judiciously switch their preference and consistently choose the easier path, illustrating their ability to adjust their behavior based on changing circumstances.
Mice carrying the grin2a mutation exhibited a strikingly different response. They persisted in their initial preference for the high-reward lever for a significantly longer duration, exhibiting a delayed adaptation to the altered reward structure. Their tendency to switch between options continued for an extended period, delaying their commitment to the more efficient choice. Zhou noted that while typical animals readily make adaptive decisions in this fluctuating environment, switching from the high-reward side to the low-reward side when the values became equivalent, the mutant animals displayed a much slower transition, indicating a deficit in their capacity for adaptive decision-making compared to their wild-type counterparts.
Through the application of advanced neuroimaging techniques, including functional ultrasound and electrophysiological recordings, the researchers were able to pinpoint the mediodorsal thalamus as the brain region most profoundly affected by the grin2a mutation. This critical area of the brain serves as a pivotal relay station, connecting the thalamus to the prefrontal cortex, thereby forming a crucial thalamocortical circuit. This circuit is fundamental for a range of higher-order cognitive functions, including decision-making, executive control, and the integration of information.
The neural activity within the mediodorsal thalamus of the mutant mice revealed distinct patterns. Specifically, the neurons in this region appeared to be less adept at tracking the changing value of different choices. Furthermore, the researchers observed discernible differences in neural firing patterns depending on whether the mice were actively exploring different options or had committed to a particular decision, suggesting a disruption in the neural encoding of decision-making processes.
Perhaps most encouragingly, the research team demonstrated that the behavioral consequences of the grin2a mutation could be reversed. Employing optogenetics, a sophisticated technique that allows for the control of genetically modified neurons using light, they engineered neurons within the mediodorsal thalamus of the mutant mice to be responsive to specific light wavelengths. Upon activation of these neurons, the mice began to exhibit behaviors that more closely resembled those of the healthy, non-mutated animals. This finding provides compelling evidence that the identified circuit plays a direct and causal role in the observed cognitive deficits.
While it is important to note that only a small subset of individuals with schizophrenia carry mutations in the grin2a gene, the researchers propose that the dysfunction observed in this specific thalamocortical circuit may represent a shared underlying mechanism contributing to cognitive impairments in a broader segment of the schizophrenia patient population. This suggests that even in cases where the grin2a gene itself is not mutated, other factors could lead to similar disruptions within this critical brain pathway.
This discovery opens up promising new avenues for therapeutic intervention. The team is actively engaged in identifying specific molecular components within this circuit that could serve as viable targets for pharmacological development. The ultimate goal is to develop treatments that can precisely modulate the activity of this circuit, thereby alleviating the debilitating cognitive symptoms associated with schizophrenia and potentially improving patients’ quality of life.
The extensive research leading to these findings was made possible through significant financial support from a consortium of leading scientific and philanthropic organizations. These include the National Institute of Mental Health, the Poitras Center for Psychiatric Disorders Research at MIT, the Yang Tan Collective at MIT, the K. Lisa Yang and Hock E. Tan Center for Molecular Therapeutics at MIT, the Stelling Family Research Fund at MIT, the Stanley Center for Psychiatric Research, and the Brain and Behavior Research Foundation. Their collective investment underscores the critical importance and potential impact of this ongoing investigation into the neurobiology of severe mental illness.
About the Author
